JP2022514501A5 - - Google Patents

Info

Publication number
JP2022514501A5
JP2022514501A5 JP2021533523A JP2021533523A JP2022514501A5 JP 2022514501 A5 JP2022514501 A5 JP 2022514501A5 JP 2021533523 A JP2021533523 A JP 2021533523A JP 2021533523 A JP2021533523 A JP 2021533523A JP 2022514501 A5 JP2022514501 A5 JP 2022514501A5
Authority
JP
Japan
Prior art keywords
nucleic acid
orf1
acid sequence
sequence
orf2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2021533523A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022514501A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/065874 external-priority patent/WO2020123753A2/en
Publication of JP2022514501A publication Critical patent/JP2022514501A/ja
Publication of JP2022514501A5 publication Critical patent/JP2022514501A5/ja
Priority to JP2024075358A priority Critical patent/JP2024102242A/ja
Withdrawn legal-status Critical Current

Links

JP2021533523A 2018-12-12 2019-12-12 細胞内治療モダリティを送達するためのアネロソーム Withdrawn JP2022514501A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024075358A JP2024102242A (ja) 2018-12-12 2024-05-07 細胞内治療モダリティを送達するためのアネロソーム

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862778866P 2018-12-12 2018-12-12
US201862778851P 2018-12-12 2018-12-12
US62/778,851 2018-12-12
US62/778,866 2018-12-12
PCT/US2019/065874 WO2020123753A2 (en) 2018-12-12 2019-12-12 Anellosomes for delivering intracellular therapeutic modalities

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024075358A Division JP2024102242A (ja) 2018-12-12 2024-05-07 細胞内治療モダリティを送達するためのアネロソーム

Publications (2)

Publication Number Publication Date
JP2022514501A JP2022514501A (ja) 2022-02-14
JP2022514501A5 true JP2022514501A5 (enExample) 2022-12-20

Family

ID=69160334

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021533523A Withdrawn JP2022514501A (ja) 2018-12-12 2019-12-12 細胞内治療モダリティを送達するためのアネロソーム
JP2024075358A Pending JP2024102242A (ja) 2018-12-12 2024-05-07 細胞内治療モダリティを送達するためのアネロソーム

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024075358A Pending JP2024102242A (ja) 2018-12-12 2024-05-07 細胞内治療モダリティを送達するためのアネロソーム

Country Status (11)

Country Link
US (1) US20220040117A1 (enExample)
EP (1) EP3894567A2 (enExample)
JP (2) JP2022514501A (enExample)
KR (1) KR20210131308A (enExample)
CN (1) CN114127302A (enExample)
AU (1) AU2019396516B2 (enExample)
BR (1) BR112021009282A2 (enExample)
CA (1) CA3119339A1 (enExample)
IL (1) IL283771A (enExample)
MX (1) MX2021006941A (enExample)
WO (1) WO2020123753A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3119814A1 (en) * 2018-12-12 2020-06-18 Flagship Pioneering Innovations V, Inc. Anellosomes for delivering protein replacement therapeutic modalities
MX2021006977A (es) * 2018-12-12 2021-10-13 Flagship Pioneering Innovations V Inc Anellosomas y metodos de uso.
AU2021288320A1 (en) * 2020-06-12 2023-01-19 Flagship Pioneering Innovations V, Inc. Tandem anellovirus constructs
KR20240114778A (ko) * 2021-12-15 2024-07-24 플래그쉽 파이어니어링 이노베이션스 브이, 인크. 표면이 변형된 바이러스 입자 및 모듈형 바이러스 입자
US20240415978A1 (en) * 2023-06-14 2024-12-19 Flagship Pioneering Innovations V, Inc. Anellovectors for delivery of effectors to the central nervous system
TW202529819A (zh) 2023-10-13 2025-08-01 美商旗艦先鋒創新公司 組織特異性指環載體(anellovector)遞送

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6395472B1 (en) * 1999-02-05 2002-05-28 Abbott Laboratories Methods of utilizing the TT virus
IL271275B1 (en) * 2017-06-13 2026-04-01 Flagship Pioneering Innovations V Inc Preparations containing croons and their uses

Similar Documents

Publication Publication Date Title
JP2022514501A5 (enExample)
JP2022512395A5 (enExample)
JP2022513797A5 (enExample)
JP2022513459A5 (enExample)
Sugano et al. Transformation by Rous sarcoma virus induces a novel gene with homology to a mitogenic platelet protein
JP2020524993A5 (enExample)
JP2023502473A5 (enExample)
KR20210131309A (ko) 분비형 치료 양식을 운반하기 위한 아넬로좀
KR20210131310A (ko) 아넬로좀 및 사용 방법
KR20210125990A (ko) 단백질 대체 치료 양식을 운반하기 위한 아넬로좀
Misawa et al. Development of 2-aminoisobutyric acid (Aib)-rich cell-penetrating foldamers for efficient siRNA delivery
JP2009535039A5 (enExample)
KR20190134506A (ko) 엠피레귤린 유전자 특이적 이중가닥 올리고뉴클레오티드 및 이를 포함하는 섬유증 관련 질환 및 호흡기 관련 질환 예방 및 치료용 조성물
JP2008054685A (ja) ウイルス感染および腫瘍抑制に関与する哺乳動物遺伝子
KR20210131308A (ko) 세포내 치료 양식을 운반하기 위한 아넬로좀
CN110431230A (zh) 慢病毒和非整合型慢病毒作为病毒载体实施crispr治疗
CA2485341A1 (en) Use of spliceosome mediated rna trans-splicing to confer cell selective replication to adenoviruses
CN115989321B (zh) 病毒制剂、用于配制病毒制剂的溶液及其用途
JP2007515966A (ja) 疾患の併用療法のための組成物および方法
Daugherty et al. Antisense RNA: effect of ribosome binding sites, target location, size, and concentration on the translation of specific mRNA molecules
JP2005519636A5 (enExample)
CN118043461A (zh) 方法
JP2018148865A (ja) ボルナウイルスベクター及びその利用
CN1770978A (zh) 利用ssDNA治疗HSV相关病理
TW202503054A (zh) 環形rna及其製備方法